BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31713776)

  • 1. Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cumulative Live-Birth Rate.
    Sacchi L; Albani E; Cesana A; Smeraldi A; Parini V; Fabiani M; Poli M; Capalbo A; Levi-Setti PE
    J Assist Reprod Genet; 2019 Dec; 36(12):2493-2504. PubMed ID: 31713776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.
    Cornelisse S; Zagers M; Kostova E; Fleischer K; van Wely M; Mastenbroek S
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD005291. PubMed ID: 32898291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The demise of preimplantation genetic testing for aneuploidy (PGT-A) in Hungary and its effect on patient care.
    Varga K; Tóth N; Bogár ÉB; Csontos L; Szabó K; Debreceni D; Margittai É; Csenki M; Vereczkey A
    Eur J Med Genet; 2019 Aug; 62(8):103669. PubMed ID: 31082515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24-chromosome single-nucleotide polymorphism-based preimplantation genetic testing for aneuploidy.
    Simon AL; Kiehl M; Fischer E; Proctor JG; Bush MR; Givens C; Rabinowitz M; Demko ZP
    Fertil Steril; 2018 Jul; 110(1):113-121. PubMed ID: 29908770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of pregnancy outcomes in preimplantation genetic testing for aneuploidy and conventional in vitro fertilization and embryo transfer: a stratified examination on the basis of the quantity of oocytes and blastocysts from a multicenter randomized controlled trial.
    Hu M; Liu M; Tian S; Guo L; Zang Z; Chen ZJ; Li Y
    Fertil Steril; 2024 Jul; 122(1):121-130. PubMed ID: 38367687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the efficacy and beneficial population of preimplantation genetic testing for aneuploidy start from the oocyte retrieval cycle: a real-world study.
    Ma S; Liao J; Zhang S; Yang X; Hocher B; Tan J; Tan Y; Hu L; Gong F; Xie P; Lin G
    J Transl Med; 2023 Nov; 21(1):779. PubMed ID: 37919732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage.
    Lee CI; Wu CH; Pai YP; Chang YJ; Chen CI; Lee TH; Lee MS
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):239-243. PubMed ID: 30910146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
    Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the associations between previous pregnancy failures and blastocyst aneuploidy as well as pregnancy outcomes after PGT-A.
    Ni T; Wu Q; Zhu Y; Jiang W; Zhang Q; Li Y; Yan J; Chen ZJ
    J Assist Reprod Genet; 2020 Mar; 37(3):579-588. PubMed ID: 32103397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
    Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
    Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
    Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
    J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016-2018.
    Sanders KD; Silvestri G; Gordon T; Griffin DK
    J Assist Reprod Genet; 2021 Dec; 38(12):3277-3285. PubMed ID: 34766235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved clinical outcomes of preimplantation genetic testing for aneuploidy using MALBAC-NGS compared with MDA-SNP array.
    Niu W; Wang L; Xu J; Li Y; Shi H; Li G; Jin H; Song W; Wang F; Sun Y
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):388. PubMed ID: 32620095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A).
    Murphy LA; Seidler EA; Vaughan DA; Resetkova N; Penzias AS; Toth TL; Thornton KL; Sakkas D
    Hum Reprod; 2019 Feb; 34(2):268-275. PubMed ID: 30500907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 1-year cumulative live birth and perinatal outcomes following single blastocyst transfer with or without preimplantation genetic testing for aneuploidy: a propensity score-matched study.
    Kato K; Ezoe K; Onogi S; Ito S; Egawa R; Aoyama N; Kuroda T; Kuwahara A; Iwasa T; Takeshita T; Irahara M
    J Assist Reprod Genet; 2023 Nov; 40(11):2669-2680. PubMed ID: 37661208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score design.
    Haviland MJ; Murphy LA; Modest AM; Fox MP; Wise LA; Nillni YI; Sakkas D; Hacker MR
    Hum Reprod; 2020 Oct; 35(10):2356-2364. PubMed ID: 32856053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rationale for biopsying embryos reaching the morula stage on Day 6 in women undergoing preimplantation genetic testing for aneuploidy.
    Irani M; Zaninovic N; Canon C; O'Neill C; Gunnala V; Zhan Q; Palermo G; Reichman D; Rosenwaks Z
    Hum Reprod; 2018 May; 33(5):935-941. PubMed ID: 29546326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preimplantation genetic testing for aneuploidy in poor ovarian responders with four or fewer oocytes retrieved.
    Deng J; Hong HY; Zhao Q; Nadgauda A; Ashrafian S; Behr B; Lathi RB
    J Assist Reprod Genet; 2020 May; 37(5):1147-1154. PubMed ID: 32285297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage.
    Neal SA; Morin SJ; Franasiak JM; Goodman LR; Juneau CR; Forman EJ; Werner MD; Scott RT
    Fertil Steril; 2018 Oct; 110(5):896-904. PubMed ID: 30316435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing.
    Cimadomo D; Soscia D; Vaiarelli A; Maggiulli R; Capalbo A; Ubaldi FM; Rienzi L
    Hum Reprod; 2019 Jul; 34(7):1206-1214. PubMed ID: 31247100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.